S-HYDROXYPROG CAPROATE 250MG/ML OIL INJ, packaged in a) 5ML b) 10ML glass vial, Red Mountain Compounding Rx
Class I - DangerousWhat Should You Do?
- Check if you have this product: Lot #:a) S06242019DH@07; 9/24/19 b) S07222019DH@09, Exp 10/22/19; S05292019DT@06, Exp 8/29/19; S06032019DT@08, Exp 9/3/19; S06242019DH@07; 9/24/19
- Do not eat it: Even if it looks and smells fine, do not consume this product.
- Throw it away or return it: You can return the product to the store for a full refund.
- Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
- Report problems: Report any issues to the FDA's Safety Reporting Portal.
⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.
Recall Details
- Company:
- First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy
- Reason for Recall:
- Lack of Assurance of Sterility
- Classification:
- Class I - Dangerous
Dangerous or defective products that predictably could cause serious health problems or death.
- Status:
- terminated
Product Information
Full Description:
S-HYDROXYPROG CAPROATE 250MG/ML OIL INJ, packaged in a) 5ML b) 10ML glass vial, Red Mountain Compounding Rx
Product Codes/Lot Numbers:
Lot #:a) S06242019DH@07; 9/24/19 b) S07222019DH@09, Exp 10/22/19; S05292019DT@06, Exp 8/29/19; S06032019DT@08, Exp 9/3/19; S06242019DH@07; 9/24/19
Official Source
Always verify recall information with the official FDA source:
View on FDA.govFDA Recall Number: D-0269-2020
Related Recalls
PYRIDOXINE HCL (B6) 100MG/ML MDV, Red Mountain Compounding Rx
First Royal Care Co. LLC
Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
METHYLCOBALAMIN 10,000MCG/ML MDV INJ, Rx only, Red Mountain Compounding Rx
First Royal Care Co. LLC
Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
TEST CYP 50MG/ML IN ETHYL OLEATE OIL, Rx only, Red Mountain Compounding Rx
First Royal Care Co. LLC
Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns